Published in Obesity and Diabetes Week, January 17th, 2005
Matria anticipates that its 2005 growth in revenues and profits will be generated primarily from the company's health enhancement segment, and in particular, through its disease management business. As in previous years, the company is providing a range of estimates for 2005 revenues and earnings to account for the variations in revenues and earnings principally attributable to potential new awards of business and the actual timing of implementation and participant enrollment in new disease management accounts.
At the low end of the range, Matria is forecasting a 61%...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.